# Focal Versus Whole Gland High Dose-Rate Brachytherapy (HDR-BT) Boost to External Beam Radiotherapy in Localized Prostate Cancer: A Phase 2 Randomized Trial

> **NCT07300566** · PHASE2 · NOT_YET_RECRUITING · sponsor: **Joelle Helou** · enrollment: 58 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **RADIATION:** Standard Arm: Whole Gland High Dose Rate Brachytherapy Boost
- **RADIATION:** Experimental Arm: Focal High Dose Rate Brachytherapy Boost

## Key facts

- **NCT ID:** NCT07300566
- **Lead sponsor:** Joelle Helou
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-02
- **Primary completion:** 2031-03
- **Final completion:** 2033-03
- **Target enrollment:** 58 (ESTIMATED)
- **Last updated:** 2025-12-24

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07300566

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07300566, "Focal Versus Whole Gland High Dose-Rate Brachytherapy (HDR-BT) Boost to External Beam Radiotherapy in Localized Prostate Cancer: A Phase 2 Randomized Trial". Retrieved via AI Analytics 2026-06-24 from https://api.ai-analytics.org/clinical/NCT07300566. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*